-
1
-
-
0035857351
-
NIH consensus development panel on osteoporosis prevention, diagnosis and treatment. Osteoporosis prevention, diagnosis, and therapy
-
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 10.1001/jama.285.6.785
-
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) NIH consensus development panel on osteoporosis prevention, diagnosis and treatment. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785-795
-
(2001)
JAMA
, vol.285
, Issue.6
, pp. 785-795
-
-
-
2
-
-
84864874370
-
What's in a name? What constitutes the clinical diagnosis of osteoporosis?
-
1:STN:280:DC%2BC38rovFyiuw%3D%3D 22543575 10.1007/s00198-012-1991-0
-
Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S (2012) What's in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int 23(8):2093-2097
-
(2012)
Osteoporos Int
, vol.23
, Issue.8
, pp. 2093-2097
-
-
Siris, E.S.1
Boonen, S.2
Mitchell, P.J.3
Bilezikian, J.4
Silverman, S.5
-
4
-
-
84966785101
-
-
US Department of Health and Human Services Accessed 18 Oct 2013
-
US Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. http://www.surgeongeneral.gov/library/reports/ bonehealth/. Accessed 18 Oct 2013
-
Bone Health and Osteoporosis: A Report of the Surgeon General
-
-
-
5
-
-
79952394479
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis
-
21224201
-
Watts NB, Bilezikian JP, Camacho PM et al (2010) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1-37
-
(2010)
Endocr Pract
, vol.16
, Issue.SUPPL. 3
, pp. 1-37
-
-
Watts, N.B.1
Bilezikian, J.P.2
Camacho, P.M.3
-
6
-
-
60849086230
-
Diagnosis and treatment of osteoporosis
-
19202966
-
Sweet MG, Sweet JM, Jeremiah MP, Galazka SS (2009) Diagnosis and treatment of osteoporosis. Am Fam Physician 79(3):193-200
-
(2009)
Am Fam Physician
, vol.79
, Issue.3
, pp. 193-200
-
-
Sweet, M.G.1
Sweet, J.M.2
Jeremiah, M.P.3
Galazka, S.S.4
-
7
-
-
84858732719
-
More bone density testing is needed, not less
-
22383457 10.1002/jbmr.1580
-
Lewiecki EM, Laster AJ, Miller PD, Bilezikian JP (2012) More bone density testing is needed, not less. J Bone Miner Res 27(4):739-742
-
(2012)
J Bone Miner Res
, vol.27
, Issue.4
, pp. 739-742
-
-
Lewiecki, E.M.1
Laster, A.J.2
Miller, P.D.3
Bilezikian, J.P.4
-
8
-
-
18844422708
-
Hip fracture in women without osteoporosis
-
1:CAS:528:DC%2BD2MXkt1Wgtrk%3D 15728213 10.1210/jc.2004-1568
-
Wainwright SA, Marshall LM, Ensrud KE et al (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787-2793
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.5
, pp. 2787-2793
-
-
Wainwright, S.A.1
Marshall, L.M.2
Ensrud, K.E.3
-
9
-
-
0035900949
-
Risk of new vertebral fracture in the year following a fracture
-
1:STN:280:DC%2BD3M7kslamtw%3D%3D 11176842 10.1001/jama.285.3.320
-
Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320-323
-
(2001)
JAMA
, vol.285
, Issue.3
, pp. 320-323
-
-
Lindsay, R.1
Silverman, S.L.2
Cooper, C.3
-
10
-
-
84857279489
-
Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women
-
22113888 10.1002/jbmr.1476
-
Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 27(3):645-653
-
(2012)
J Bone Miner Res
, vol.27
, Issue.3
, pp. 645-653
-
-
Gehlbach, S.1
Saag, K.G.2
Adachi, J.D.3
-
11
-
-
34548359372
-
Prior fractures are common in patients with subsequent hip fractures
-
17415014
-
Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226-230
-
(2007)
Clin Orthop Relat Res
, vol.461
, pp. 226-230
-
-
Edwards, B.J.1
Bunta, A.D.2
Simonelli, C.3
Bolander, M.4
Fitzpatrick, L.A.5
-
12
-
-
0942268144
-
Fracture incidence and association with bone mineral density in elderly men and women: The Rotterdam Study
-
1:STN:280:DC%2BD2c%2FltVCjsg%3D%3D 14751578 10.1016/j.bone.2003.10.001
-
Schuit SCE, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1):195-202
-
(2004)
Bone
, vol.34
, Issue.1
, pp. 195-202
-
-
Schuit, S.C.E.1
Van Der Klift, M.2
Weel, A.E.3
-
13
-
-
2442654174
-
Bone mineral density thresholds for pharmacological intervention to prevent fractures
-
15159268 10.1001/archinte.164.10.1108
-
Siris ES, Chen Y, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108-1112
-
(2004)
Arch Intern Med
, vol.164
, Issue.10
, pp. 1108-1112
-
-
Siris, E.S.1
Chen, Y.2
Abbott, T.A.3
-
14
-
-
43149104354
-
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: Results from the National Osteoporosis Risk Assessment (NORA)
-
1:STN:280:DC%2BD1c3hslKmsg%3D%3D 18058055 10.1007/s00198-007-0508-8
-
Barrett-Connor E, Sajjan SG, Siris ES, Miller PD (2008) Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 19(5):607-613
-
(2008)
Osteoporos Int
, vol.19
, Issue.5
, pp. 607-613
-
-
Barrett-Connor, E.1
Sajjan, S.G.2
Siris, E.S.3
Miller, P.D.4
-
16
-
-
46649091797
-
Cost-effective osteoporosis treatment thresholds: The United States perspective
-
1:STN:280:DC%2BD1c7nvF2ntg%3D%3D 2729707 18292976 10.1007/s00198-007- 0550-6
-
Tosteson AN, Melton LJ III, Dawson-Hughes B et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437-447
-
(2008)
Osteoporos Int
, vol.19
, Issue.4
, pp. 437-447
-
-
Tosteson, A.N.1
Melton III, L.J.2
Dawson-Hughes, B.3
-
17
-
-
34247866550
-
Once-yearly zoledronic acid for the treatment of postmenopausal osteoporosis
-
1:CAS:528:DC%2BD2sXltVSktLc%3D 17476007 10.1056/NEJMoa067312
-
Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for the treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809-1822
-
(2007)
N Engl J Med
, vol.356
, Issue.18
, pp. 1809-1822
-
-
Black, D.M.1
Delmas, P.D.2
Eastell, R.3
-
18
-
-
35748967004
-
Zoledronic acid and clinical fractures and mortality after hip fracture
-
1:CAS:528:DC%2BD2sXht1Kit7nN 17878149 10.1056/NEJMoa074941
-
Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799-1809
-
(2007)
N Engl J Med
, vol.357
, Issue.18
, pp. 1799-1809
-
-
Lyles, K.W.1
Colon-Emeric, C.S.2
Magaziner, J.S.3
-
19
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
1:CAS:528:DC%2BD3MXktVSgsbw%3D 11346808 10.1056/NEJM200105103441904
-
Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434-1441
-
(2001)
N Engl J Med
, vol.344
, Issue.19
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
-
20
-
-
63949087159
-
Ten-year fracture probability identifies women who will benefit from clodronate therapy - Additional results from a double-blind, placebo- controlled randomised study
-
1:CAS:528:DC%2BD1MXjvFaqt78%3D 19002369 10.1007/s00198-008-0786-9
-
McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy - additional results from a double-blind, placebo- controlled randomised study. Osteoporos Int 20(5):811-817
-
(2009)
Osteoporos Int
, vol.20
, Issue.5
, pp. 811-817
-
-
McCloskey, E.V.1
Johansson, H.2
Oden, A.3
-
21
-
-
84861304688
-
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The Fracture Intervention Trial
-
1:CAS:528:DC%2BC38XhtVequ77F 22492479 10.1002/jbmr.1625
-
Donaldson MG, Palermo L, Ensrud K, Hochberg MC, Schousboe JT, Cummings SR (2012) Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res 27(8):1804-1810
-
(2012)
J Bone Miner Res
, vol.27
, Issue.8
, pp. 1804-1810
-
-
Donaldson, M.G.1
Palermo, L.2
Ensrud, K.3
Hochberg, M.C.4
Schousboe, J.T.5
Cummings, S.R.6
-
22
-
-
34247194211
-
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
-
17144789 10.1359/jbmr.061113
-
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465-475
-
(2007)
J Bone Miner Res
, vol.22
, Issue.3
, pp. 465-475
-
-
Burge, R.1
Dawson-Hughes, B.2
Solomon, D.H.3
Wong, J.B.4
King, A.5
Tosteson, A.6
|